fractions. Further purification was carried out by column
chromatography (silica), eluting with CH2Cl2/Et2O (30%) to
obtain the porphyrin isomer 11a and with CH2Cl2/Et2O (40%)
to obtain the porphyrin isomer 12a. A final purification on both
fractions was carried out by preparative TLC plates using
CH2Cl2/Et2O (20%) as the eluent.
solution filtered, and saturated NH4PF6 solution added to the
filtrate until no further precipitation was evident. The [2]-
catenane product was collected by filtration, washed (water),
and pumped dry. The solid was then washed with acetone and
the filtrate recrystallised (from acetone/iPr2O) to obtain the
porphyrin [2]-catenane 16b as a dark purple solid (39 mg, 21%),
mp 200–204 ЊC; m/z (FAB) [M]ϩ 2612.0 (calcd 2612.79), [M–
PF6]ϩ 2467.0 (calcd 2467.83), [M-2PF6]ϩ 2322.0 (calcd 2322.86),
[M-3PF6]ϩ 2177.0 (calcd 2177.90), [M-tetracation-PF6]ϩ 1511.3
(calcd 1512.67); δH (300 MHz; DMSO-d6; 363K) 9.74 (2H, s,
H-1), 8.22 (8H, d, J 6, α-bipy), 7.82 (2H, t, J 9, H-13), 7.62 (2H,
d, J 8, H-14), 7.55 (2H, d, J 8, H-11), 7.46 (8H, s, phenylene),
7.39 (2H, t, J 8, 12), 6.59 (8H, d, J 6, β-bipy), 6.43 (4H, s, H-33),
5.21 (8H, s, Nϩ–CH2), 4.28 (4H, m, H-16), 3.99 (4H, m, OCH2),
3.84 (8H, m, H-4), 3.67–3.62 (24H, m, H-21, H-22, 4 × OCH2),
3.61 (4H, m, OCH2), 3.57 (4H, m, OCH2), 3.37 (4H, m, H-17),
3.00 (4H, m, OCH2), 2.93 (16H, s, H-7, OCH2), 2.88 (4H, m,
OCH2), 1.68 (12H, t, J 8, H-5).
18b was also collected and recrystallised in the same manner
(15 mg, 6%), mp 234–237 ЊC; m/z (FAB)- [M]ϩ 3712.4 (calcd
3712.91), [M–PF6]ϩ 3567.7 (calcd 3567.95), [M-2PF6]ϩ 3423.2
(calcd 3422.98), [M-3PF6]ϩ 3279.3 (calcd 3278.02),
[M-4PF6]ϩ 3133.3 (calcd 3133.06), [M-5PF6]ϩ 2988.4 (calcd
2988.09), [M-tetracation-5PF6]ϩ 2467.5 (calcd 2467.83), [M-
tetracation-5PF6]ϩ 2323 (calcd 2322.86), [parent porphyrin]ϩ
1511.7 (calcd 1512.67); δH (300 MHz; DMSO-d6; 363 K)
9.70 (2H, s, H-1), 8.58 (16H, d, J 6, α-bipy), 7.87 (2H, t, J 9,
H-13), 7.67–7.63 (4H, m, H-14, H-11), 7.60 (16H, s, phenylene),
7.46 (2H, t, J 8, H-12), 7.12 (16H, d, J 6, β-bipy), 5.45 (16H, m,
Nϩ–CH2), 4.40 (4H, m, H-16), 3.87 (8H, m, H-4), 3.80–3.68
(28H, m, H-21, H-22, H-33, 4 × OCH2), 3.60 (4H, m, OCH2),
3.51 (4H, m, H-17), 3.40 (4H, m, OCH2), 3.31–3.26 (8H, m,
OCH2), 2.93 (20H, s, H-7, OCH2), 1.70 (12H, t, J 8, H-5).
11a was recrystallised to obtain a purple/red solid (45 mg,
14%), m.p. 155–158 ЊC (from CH2Cl2/MeOH) (Found: C, 69.66;
H, 7.03; N, 3.80. C86H104O16N4.2H2O requires C, 69.52; H, 7.33;
N, 3.77%); m/z (ESMS) [M ϩ H]ϩ 1450.4 (calcd. 1449.7), [M ϩ
2H]2ϩ 725.7 (calcd. 725.4); UV (λ nm, CHCl3) 410, 507, 541,
574, 626; δH (300 MHz; CDCl3) 10.20 (2H, s, H-meso), 7.83–
7.77 (4H, m, Ar–H), 7.40 (2H, t, J 8, Ar–H), 7.34 (2H, d, J 9,
Ar–H), 6.89 (4H, s, Ar–H), 5.86 (4H, d, J 9, Ar–H), 5.20 (4H, d,
J 9, Ar–H), 4.17 (4H, t, J 4, OCH2), 4.10 (4H, t, J 4, OCH2),
4.00 (8H, m, CH2CH3), 3.87 (4H, t, J 4, OCH2), 3.75–3.66
(24H, m, OCH2), 3.20 (4H, t, J 4, OCH2), 2.59 (12H, s, CH3),
2.06 (4H, t, J 4, OCH2), 1.77 (12H, t, J 8, CH3CH2), 1.63 (4H, t,
J 4, OCH2), 1.28 (4H, s, 2H2O), Ϫ2.27 (2H, br s, pyrrole NH).
12a was recrystallised to obtain a purple/red solid (12 mg,
4%), mp 142–145 ЊC (from CH2Cl2/MeOH) (Found: C, 69.98;
H, 6.93; N, 3.85. C86H104O16N4.H2O requires C, 70.37; H, 7.28;
N, 3.82%); m/z (ESMS) [M ϩ H]ϩ 1450.4 (calcd. 1449.7), [M ϩ
2H]2ϩ 725.7 (calcd. 725.4); UV (λ nm, CHCl3) 410, 507, 541,
573, 626; δH (300 MHz; CDCl3) 10.21 (2H, s, H-meso), 7.82–
7.77 (4H, m, Ar–H), 7.39 (2H, t, J 8, Ar–H), 7.32 (2H, d, J 9,
Ar–H), 6.54 (4H, s, Ar–H), 5.84 (4H, d, J 9, Ar–H), 5.24 (4H, d,
J 9, Ar–H), 4.18 (4H, t, J 4, OCH2), 4.01 (8H, m, CH2CH3),
3.80 (4H, t, J 4, OCH2), 3.70 (8H, m, OCH2), 3.62 (20H, m,
OCH2), 3.10 (4H, t, J 4, OCH2), 2.60 (12H, s, CH3), 2.07 (4H, t,
J 4, OCH2), 1.79 (12H, t, J 8, CH3CH2), 1.72 (4H, t, J 4, OCH2),
1.28 (2H, s, H2O), Ϫ2.25 (2H, br s, pyrrole NH); δC (CDCl3)
158.6, 152.9, 152.1, 152.0, 145.4, 144.4, 140.9, 135.8, 134.5,
131.3, 130.3, 121.1, 115.4, 114.6, 114.2, 111.8, 96.1, 70.9, 70.8,
69.8, 69.3, 68.7, 67.9, 67.7, 65.6, 19.9, 17.7 and 13.7.
[2] catenane 15b and [3]catenane 17b. The free base 1,4-dioxy-
benzene (2,4,4,2) α,α-porphyrin 12a (183 mg, 1.26 × 10Ϫ4mol)
1,1Ј-[1,4-phenylenebis(methylene)]bis(4,4Ј-bipyridinium)bis-
(hexafluorophosphate)27 13 (370 mg, 5.30 × 10Ϫ4mol), 1,4-
bis(bromomethyl)benzene (170 mg, 6.62 × 10Ϫ4mol), and cata-
lytic amounts of NaI and NH4PF6 were dissolved in DMF
(7 mL), then stirred at room temperature at 12 kbar for 6 days.
The solvent was removed under vacuum with heating, and the
residue washed well with CH2Cl2, followed by hot water. Purifi-
cation was carried out by column chromatography (silica) by
eluting initially with CH2Cl2/MeOH (10%), then MeOH/2M
NH4Cl solution/MeNO2 (7:2:1 v/v) to obtain the [2]-catenane
fraction 15b, followed by MeOH/2M NH4Cl solution/DMF
(4:5:2 v/v) to obtain the [3]-catenane 17b. The [2]-catenane
fraction was taken to dryness, the residue dissolved in a mini-
mum amount of MeOH/water/acetone, and a solution of
Zn(OAc)2 in MeOH was added and allowed to stir at room
temperature for 1 h. The acetone was then removed, the solu-
tion filtered, and saturated NH4PF6 solution added to the fil-
trate until no further precipitation was evident. The product
was collected by filtration, washed (water), and pumped dry.
The solid was then washed with acetone and the filtrate
recrystallised to obtain the porphyrin [2]catenane 15b as a dark
purple solid (24 mg 13%), mp 200–204 ЊC (from acetone/iPr2O);
m/z (FAB) [M]ϩ 2612.0 (calcd 2612.79), [M–PF6]ϩ 2467.5 (calcd
2467.83), [M-2PF6]ϩ 2323.0 (calcd 2322.86), [M-3PF6]ϩ 2177.0
(calcd 2177.90), [M-tetracation-4PF6]ϩ 1511.7 (calcd 1512.67);
δH (300 MHz; CD3COCD3; 300 K) 9.94 (2H, s, H-1), 8.08 (8H,
d, J 6, α-bipy), 7.89 (2H, t, J 9, H-13), 7.72–7.65 (2H, d, J 8,
H-14, H-14Ј), 7.46 (2H, d, J 8, H-11), 7.41 (2H, t, J 8, H-12),
7.26 (8H, s, phenylene), 7.00 (2H, d, J 8, H-21), 6.81 (2H, d, J 8,
H-22), 6.17 (4H, d, J 8, H-33), 6.06 (8H, bs, β-bipy), 5.32 (8H,
m, Nϩ–CH2), 4.79 (2H, m, H-16), 4.61 (2H, m, H-16Ј), 4.17
(4H, m, H-4), 3.82–3.45 (24H, m, H-4Ј, H-17, H-24, H-19,
H-18, H-31, 2 × OCH2), 3.29 (6H, m, H-19Ј, OCH2), 2.71 (12H,
m, H-24Ј, H-18Ј, 2 × OCH2), 2.59 (16H, bs, H-7, H-21Ј, H-22Ј),
Zinc 1,4-dioxybenzene(2,4,4,2)porphyrin 12b
Zinc was inserted into the 1,4-dioxybenzene (2,4,4,2) porphyrin
H2(3HQ)2,4,4,2P 12a to give 12b, which was recrystallised to
obtain a purple/pink solid, mp 73–77 ЊC (from CH2Cl2/
heptane); UV (λ nm, CHCl3) 412, 540, 575; δH (300 MHz;
CDCl3) 10.16 (2H, s, H-meso), 7.80 (4H, m, Ar–H), 7.39 (2H, t,
J 8, Ar–H), 7.34 (2H, d, J 7, Ar–H), 6.60 (4H, s, Ar–H), 6.06
(4H, d, J 9, Ar–H), 5.48 (4H, d, J 9, Ar–H), 4.18 (4H, t, J 4,
OCH2), 4.02 (8H, m, CH2CH3), 3.82 (4H, t, J 4, OCH2), 3.68
(12H, m, OCH2), 3.60 (16H, m, OCH2), 3.11 (4H, t, J 4, OCH2),
2.58 (12H, s, CH3), 2.15 (4H, t, J 4, OCH2), 2.03 (4H, m,
OCH2), 1.78 (12H, t, J 8, CH3CH2).
Catenanes 15, 16, 17 and 18
[2]catenane 16b and [3]catenane 18b. The free base 1,4-di-
oxybenzene (2,4,4,2) α,β-porphyrin (161 mg, 1.11 × 10Ϫ1 mmol)
1,1Ј-[1,4-phenylenebis(methylene)]bis(4,4Ј-bipyridinium)bis-
(hexa-fluorophosphate) 13 (330 mg, 4.67 × 10Ϫ1 mmol), 1,4-
bis(bromomethyl)benzene (150 mg, 5.83 × 10Ϫ1 mmol), and
catalytic amounts of NaI and NH4PF6 were dissolved in DMF
(7 mL), then stirred at room temperature at 12 kbar for 6 days.
The solvent was removed under vacuum with heating, and the
residue washed well with CH2Cl2, followed by hot water. Purifi-
cation was carried out by column chromatography (silica) by
eluting initially with CH2Cl2/MeOH (10%), then MeOH/2M
NH4Cl solution/MeNO2 (7:2:1 v/v) to obtain the [2]-catenane
fraction 16a, followed by MeOH/2M NH4Cl solution/DMF
(4:5:2 v/v) to obtain the [3]-catenane 18a. The [2]-catenane
fraction was taken to dryness, the residue dissolved in a
minimum amount of MeOH/water/acetone, and a solution of
Zn(OAc)2 in MeOH was added and allowed to stir at room
temperature for 1 h. The acetone was then removed, the
O r g . B i o m o l . C h e m . , 2 0 0 3 , 1, 4 0 9 7 – 4 1 1 2
4110